FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,317,680 | +18.0% | 522,000 | -12.3% | 0.01% | +20.0% |
| Q2 2023 | $1,964,490 | +162.5% | 595,300 | +126.7% | 0.01% | +150.0% |
| Q1 2023 | $748,410 | +60.6% | 262,600 | +310.3% | 0.00% | +100.0% |
| Q4 2022 | $465,920 | +14.5% | 64,000 | +27.2% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -25.3% | 50,300 | -54.8% | 0.00% | -50.0% |
| Q2 2022 | $545,000 | -73.0% | 111,300 | +30.2% | 0.00% | -60.0% |
| Q1 2022 | $2,022,000 | -69.8% | 85,500 | -77.4% | 0.01% | -70.6% |
| Q4 2021 | $6,706,000 | +67.2% | 379,100 | +166.6% | 0.02% | +70.0% |
| Q3 2021 | $4,011,000 | – | 142,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |